Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway
Animal Models and Experimental Medicine · 2023-12 · 6 (6) · 573-584
DOI: 10.1002/ame2.12342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 11.08.2023. Verfasst von Wei Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Cente…. Hauptthemen laut MEDLINE: Integrin alpha5, Osteogenesis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, CAMS Innovation Fund for Medical Sciences, Clinical Medicine Plus X - Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Background
The effect of platelet factor 4 (PF4) on bone marrow mesenchymal stem cells (BMMSCs) and osteoporosis is poorly understood. Therefore, this study aimed to evaluate the effects of PF4‐triggered bone destruction in mice and determine the underlying mechanism.
Methods
First, in vitro cell proliferation and cell cycle of BMMSCs were assessed using a CCK8 assay and flow cytometry, respectively. Osteogenic differentiation was confirmed using staining and quantification of alkaline phosphatase and Alizarin Red S. Next, an osteoporotic mouse model was established by performing bilateral ovariectomy (OVX). Furthermore, the PF4 concentrations were obtained using enzyme‐linked immunosorbent assay. The bone microarchitecture of the femur was evaluated using microCT and histological analyses. Finally, the key regulators of osteogenesis and pathways were investigated using quantitative real‐time polymerase chain reaction and Western blotting.
Results
Human PF4 widely and moderately decreased the cell proliferation and osteogenic differentiation ability of BMMSCs. Furthermore, the levels of PF4 in the serum and bone marrow were generally increased, whereas bone microarchitecture deteriorated due to OVX. Moreover, in vivo mouse PF4 supplementation triggered bone deterioration of the femur. In addition, several key regulators of osteogenesis were downregulated, and the integrin α5‐focal adhesion kinase‐extracellular signal‐regulated kinase (ITGA5‐FAK‐ERK) pathway was inhibited due to PF4 supplementation.
Conclusions
PF4 may be attributed to OVX‐induced bone loss triggered by the suppression of bone formation in vivo and alleviate BMMSC osteogenic differentiation by inhibiting the ITGA5‐FAK‐ERK pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Pathology, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biom…
- Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Orthopedics, Beijing Hospital and National Center of Gerontology and Institute of Geriatrics Medicine, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Orthopedics, Beijing Eden Hospital, Beijing, China.
- Department of Prosthodontics, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biom…
- The Central Laboratory, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biomateria…
ORCID-Profile: Hao Liu
Förderung
- Beijing Natural Science Foundation
- CAMS Innovation Fund for Medical Sciences
- Clinical Medicine Plus X - Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Li, W., Zhang, Q., Gu, R., Zeng, L., & Liu, H. (2023). Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway. Animal Models and Experimental Medicine, 6(6), 573-584. https://doi.org/10.1002/ame2.12342
Vancouver
Li W, Zhang Q, Gu R, Zeng L, Liu H. Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway. Animal Models and Experimental Medicine. 2023;6(6):573-584. doi:10.1002/ame2.12342
BibTeX
@article{Li2023,
author = {Li, Wei and Zhang, Qiwei and Gu, Ranli and Zeng, Lijun and Liu, Hao},
title = {Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway},
journal = {Animal Models and Experimental Medicine},
year = {2023},
volume = {6},
number = {6},
pages = {573--584},
doi = {10.1002/ame2.12342}
}
EUVIMED